TP53 and pancreatic neoplasm: All variants found in this cohort of pancreatic tumors were pathogenic mutations (according to the Varsome database), except for one TP53 mutation, two RNF43 variants, and two SMAD4 alterations (classified as VUS—variant of uncertain significance).